Schedule 13G ownership disclosure
Cytokinetics Inc
COMMON STOCK · CUSIP: 23282W605
Event date: 2025-04-30
- Filing-level shares
- 13,420,144
- Percent of class
- 11.3%
- T. Rowe Price Investment Management, Inc.
Shares: 13,420,144 · Class: 11.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000123
- Form type
- SCHEDULE 13G
- Filer
- CYTOKINETICS INC
- CIK
- CIK 1061983
- Filed
- May 07, 2025
- Reporting period
- Apr 30, 2025
- Description
- Schedule 13G beneficial ownership